Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity
Objectives: Acyclovir is approved to treat herpes simplex virus (HSV) type 1, type 2 and varicella-zoster virus. It is mainly eliminated via the kidneys, for which drug crystals accumulation might lead to nephrotoxicity. This study aimed to determine the incidence, risk factors, preventive measures,...
| Published in: | Saudi Pharmaceutical Journal |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Springer
2022-06-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016422000925 |
